Yamanaka lab preprint: partial reprogramming outcomes diverge sharply by cell lineage

MaxUnfried · x · 2026-11-14

A new preprint from Shinya Yamanaka's lab at the Gladstone Institutes uses reversible, traceable Sendai-OSKM to test whether partial reprogramming makes human cells biologically younger while recovering identity and function. Outcomes diverged by lineage:

The study, "Partial reprogramming reveals lineage-specific uncoupling of rejuvenation, function, and recoverability in human cells," concludes rejuvenation, function, and recoverability are uncoupled across lineages—so therapies must be optimized per lineage. Commenter Max Unfried notes this is unlikely to extend lifespan much or deliver true cellular rejuvenation.

Original post →

More from Research

Research channel →